Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Webster Financial Corporation Announces Q1 2025 Earnings Release and Conference Call
-
T. Marzetti Company Names Tanya Berman Retail President
-
Diversified Healthcare Trust First Quarter 2025 Conference Call Scheduled for Tuesday, May 6th
-
Broadcom Inc. Announces $10 Billion Share Repurchase Authorization
-
EPR Properties First Quarter 2025 Earnings Conference Call Scheduled for May 8, 2025
-
Elme Communities to Release First Quarter 2025 Results on Thursday, May 1st
-
CACI Awarded $66 Million Task Order to Provide Expertise to U.S. Navy Naval Surface Warfare Center (NSWC)
-
Grand Canyon Education, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details
-
Brighthouse Financial Announces Conference Call to Discuss First Quarter 2025 Results
-
Greenbrier announces Second Quarter financial results
-
Assurant to Announce First Quarter 2025 Financial Results
-
C.H. Robinson Announces Dorothy Capers as New Chief Legal Officer and Secretary
-
Goldman Sachs BDC, Inc. Schedules Earnings Release and Conference Call to Announce First Quarter 2025 Results
-
Equity Residential Announces First Quarter 2025 Earnings Release Date
-
Accel Entertainment Names Scott Levin as Chief Legal Officer
-
PayPal Announces Retirement of Rodney C. Adkins from Board of Directors
-
Franklin Street Properties Corp. Declares Quarterly Dividend
-
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2025
-
New Mountain Finance Corporation Schedules its First Quarter 2025 Earnings Release and Conference Call
-
Abacus Global Management Well-Positioned Amid Market Volatility
-
Innventure, Inc. to Announce Fourth Quarter and Full Year 2024 Results on April 11
-
CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)
-
Presidio Property Trust Announces Series D Preferred Stock Cash Dividend
-
Nasdaq Reports March 2025 Volumes and 1Q25 Statistics
-
Federated Hermes, Inc. announces first quarter 2025 earnings and conference call dates
-
New Story Schools Lancaster to Relocate to Circleville for 2025-2026 School Year
-
Levi Strauss & Co. Reports Better Than Expected First-Quarter 2025 Financial Results
-
Primaris REIT Announces Distribution for April 2025
-
Superspecs Helps Ohio Gear Up for Sports Eye Safety Month
-
Bar Tender by Wingstop: The First Bar Dedicated to Chicken Tenders, Served in 12 Bold Flavors
-
5 Surprising Earth Day Myth-Busters: MRA Reveals How the Roof on Your Home Actually Impacts the Planet
-
FIRST FINANCIAL BANK NAMED NUMBER THREE BANK IN THE NATION BY FORBES
-
Huntsman to Discuss First Quarter 2025 Results on May 2, 2025
-
Second Tranche Closing of US$4 Million Private Placement
-
Vox Royalty Reports Major Financing Development at the Bullabulling Gold Project and Provides Western Australian Gold Sector Update
-
Adeia to Release First Quarter 2025 Financial Results on May 5, 2025
-
ThredUp to Report First Quarter 2025 Financial Results on May 5, 2025
-
Orion Group Holdings to Report First Quarter 2025 Financial Results on Tuesday, April 29
-
Brookline Bancorp, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
-
Dave & Buster's Reports Fourth Quarter and Fiscal Year End 2024 Financial Results; Repurchases $108 Million of Shares and Executes Sale Leaseback of Five Properties for $111 Million
-
Solésence Announces Uplisting to Nasdaq
-
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
-
NEVADA KING ANNOUNCES FULLY ALLOCATED NON-BROKERED OFFERING OF $11 MILLION, WELCOMES PROMINENT U.S. BASED GOLD FUND AS NEW SHAREHOLDER
-
CVRx Reports Preliminary First Quarter 2025 Financial Results
-
PRA Group Announces Leadership Succession Plan
-
Rumble & Rebel News sue MP Saks & others for conspiring to violate free speech rights
-
Enterprise Financial Services Corp Announces First Quarter 2025 Earnings Release and Conference Call
-
Tyson Foods Announces Second Quarter Earnings Conference Call and Webcast
-
Savara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at Two Upcomi
-
AAR, KIRA establish KALS LLC joint venture, awarded E-6B contract by U.S. Navy

